Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and ...
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the ...
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on ...
At issue is a report released by the FTC in July called: “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug ...
The FTC brought action against the top PBMs — CVS Health's Caremark Rx, Cigna's Express Scripts, and United Health ...
Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback